NQO1 and cancer: As noted above, several nitroreductases, including the mammalian NQO1, are upregulated in cancer cells [2, 3] and our finding that CNOB alone has little anticancer effectiveness in mice [11] suggests that these enzyme levels must be ineffectual in activating this prodrug for treatment purposes.